Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children. (2021)

First Author: Turkova A

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2108793

PubMed Identifier: 34965338

Publication URI: http://europepmc.org/abstract/MED/34965338

Type: Journal Article/Review

Volume: 385

Parent Publication: The New England journal of medicine

Issue: 27

ISSN: 0028-4793